Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001437749-26-037745

Options or other derivatives

  • Director acquired 4,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

George Robert E. · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2026-11-17 Grant or award : show line 1 in the form Stock Options (right to buy) +4,000 $6.83 2036-11-17 4,000 4,334 D
Loading xslF345X06/rdgdoc.xml…